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Abstract
Background: Thromboembolic complications resulting from radiofrequency catheter abla-
tion (RFCA) have an overall incidence of 0.6%. Multiple intracardiac catheters are often
necessary for electrophysiological study and RFCA therapy. Therefore, the placement of multi-
ple venous sheaths in one femoral vein is always required for multiple intracardiac catheter
insertion. The safety of the placement of multiple separate venous sheaths has been studied
previously in a non-randomized study, but the placement of multiple sheaths via one venous
line has not been fully studied.
Methods and Results: A randomized clinical trial was conducted with a total of 200 patients.
We studied the safety of placing multiple sheaths via one venous line, and the effect of heparin
on deep vein thrombosis (DVT) and on in situ thrombosis. DVT was not seen in our patients.
We observed a significant decrease in the rate of in situ thrombosis in patients who received
heparin during the procedure (28% vs 11%, p = 0.04). The type of cannulation changed the in
situ thrombosis rate independently of the heparinization protocol. The rate of in situ thrombo-
sis was higher when placing sheaths via one venous line regardless of the heparinization
protocol used (16% vs 6%, p = 0.1 for the group on heparin, and 38% vs 18%, p = 0.04 for
the other group). In the group cannulated with only one venous line (100 patients), hepariniza-
tion significantly decreased the rate of in situ thrombosis (16% vs 38%, p = 0.023), but there
was an insignificant decrease in the separate cannulation group (6% vs 18%, p = 0.12).
Advanced age had no effect on thrombosis. Surprisingly, there was a significantly greater rate
of in situ thrombosis (not DVT) among women than among men (26% vs 11%, p = 0.01),
regardless of the heparinization protocolor the type of cannulation.
Conclusions: Given the local venous complications and DVT after electrophysiological proce-
dures, heparinization is not necessary for right-sided electrophysiological procedures. In situ
thrombosis is a minor complication that can be reduced by heparinization in patients undergoing
one-line cannulation and in women during longer procedures. (Cardiol J 2012; 19, 1: 15–19)
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Introduction
Radiofrequency catheter ablation (RFCA) is an
established effective therapy for the treatment of
many cardiac tachyarrhythmias. The chief limitation
of conventional RFCA continues to be the risk of
thromboembolism. Thromboembolic complications
of RFCA have an overall incidence of 0.6%. How-
ever, the risk is increased when ablation is per-
formed in the left heart (1.8% to 2%) and for ven-
tricular tachycardia (2.8%) [1–6].
Embolization from venous sheaths or right-sid-
ed RF lesions causes deep vein thrombosis, free-
floating right atrial thrombosis, and pulmonary
embolism, all of which may be clinically silent [7].
Multiple intracardiac catheters are often ne-
cessary for electrophysiological study (EPS) and
RFCA. Therefore, the placement of multiple venous
sheaths through one femoral vein is always required
for multiple intracardiac catheter insertion. Severe
clinical problems such as pulmonary emboli follow-
ing local venous thrombosis are rare, but lethal and
devastating. Nevertheless, these complications are
worth taking into account. Thrombogenecity of
multiple catheters were documented by previous
studies [8, 9]. The safety of placing multiple sepa-
rate venous sheaths has been studied previously in
a non-randomized study [10], but the placement of
multiple sheaths via just one line has not been fully
studied.
We studied the safety of placing multiple
sheaths via one line, and the effect of heparin on the
incidence of vascular complications and on the risk
of in situ and deep vein thrombosis (DVT). This is
the first randomized study regarding the local venous
complications resulting from EPS procedures.
Methods
Study population
A prospective randomized clinical trial was
conducted, with 200 patients undergoing right heart
EPS/RFCA for the diagnosis and/or treatment of
right-sided supraventricular and ventricular tachy-
arrhythmias. All patients gave informed consent
before inclusion in the study. Patients were eligi-
ble if they were at least 15 years old and weighed
at least 45 kg.
Study design
EPS and RFCA procedures were performed
according to established practices. All RFCA proce-
dures were performed in the temperature-controlled
mode to keep the patients in a lower coaguability
state (60oC) [11]. The percutaneous Seldinger tech-
nique was used to access the lower extremity.
Then, two or three sheaths (6 to 7 F) were in-
serted into one or both femoral veins through a sin-
gle venous puncture or using separate cannulation
according to the study protocol. The number of in-
dwelling sheaths or catheters was determined by
the operator, based on the clinical requirements.
Heparin was administered with a loading dose of
5,000 U to one group but was not given to the con-
trol group. The activated clotting time (ACT) was
monitored to assess the level of anticoagulation
achieved. After the procedure, all sheaths were
removed in the electrophysiology laboratory. All
patients rested in bed for six hours.
For all patients, a data sheet was filled in by
the operator. This data sheet included the number
of catheters used on the right (and left, if present),
the number of needle insertions in both sides, the
presence of in situ thrombosis during catheter re-
moval as a strand of thrombus connected to the tip
of the catheter, and the duration of the procedure.
In situ thrombosis was detected and documented
by the first procedure operator.
Duplex ultrasonography evaluation
Duplex ultrasonography evaluation of the bila-
teral or unilateral lower leg veins, including the proxi-
mal femoral vein, was done to evaluate the venous
flow pattern, thrombus formation, hematoma,
thrombophlebitis, and DVT 24 hours after the pro-
cedure. Duplex ultrasound images were taken in the
supine position with a 10 MHz linear probe. Duplex
criteria for complete venous thrombosis with occlu-
sion were defined as the absence of flow and an in-
compressible venous segment. A patent femoral vein
was defined as a completely compressible vein with
spontaneous phasic flow. The operator was unaware
of which group a patient belonged to. All patients
were asked about pain at the catheter site, dyspnea,
pleuretic chest pain, and were examined for evidence
of hematoma at the catheterization site.
Statistical methods
Continuous variables were presented as the
mean ± standard deviation and were compared us-
ing paired and unpaired Student’s t test where ap-
propriate. Differences in mean values between
groups were assessed using the Student t test. Cate-
gorical data were compared using Fisher’s exact test.
Statistical analysis was subsequently carried out
with univariate and multivariate analysis using lo-
gistic regression analysis. All above analyses were
considered significant at p < 0.05 (two tailed). We
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used SPSS 15.0 (SPSS Inc., Chicago, USA) for data
storage and analysis.
Results
Patient characteristics
and periprocedural outcomes
In the 200 patients enrolled, there were 333 fe-
moral veins approaches (200 right femoral vein
approaches and 133 left femoral vein approaches).
All veins contained two or more catheters that were
inserted either through a single or multiple sepa-
rate venous punctures.
Of the 200 patients, 111 were women, 89 were
men; background heart disease of the patients in-
cluded cardiomyopathy in 22, coronary heart dis-
ease in 19, and valvular heart disease in seven; 151 pa-
tients had no underlying heart disease (Table 1).
In situ thrombosis was detected and document-
ed by the first procedure operator. The rate of in
situ thrombosis was not different in smokers vs non-
-smokers (p = NS), in patients with obesity (p = 0.7),
and in whom the hemoglobin was less than 12
(p = 0.55). There was a trend of more in situ throm-
bosis in patients with severe left ventricular systo-
lic dysfunction (EF < 20%, p = 0.23) and in diabetics
vs non-diabetics patients (26.3% vs 18.9%, p = 0.5).
Aspirin administration before the procedure had no
effect on the rate of thrombosis (p = NS).
Table 1. Patients’ clinical characteristics.
Frequency Percentage
Diabetes mellitus 19 9.5
Cigarette smoking 16 8.0
Obesity 19 9.5
DVT risk factors (N)
0 153
1 44 22.0
2 3 1.5
Total 200 100.0
Hemoglobin [mg/dL]
≥ 12 122 61.0
£ 10 but < 12 66 33.0
Total 200 100.0
LV systolic function
Normal 170 85.0
Mildly reduced 6 3.0
Moderately reduced 14 7.0
Severely reduced 10 5.0
Total 200 100.0
DVT — deep vein thrombosis; LV — left ventricle
We found a significant difference between the
rate of thrombosis in patients in whom the sheaths
were inserted though a single venous puncture and
those in whom the sheaths were inserted through
multiple venous punctures (Table 2).
A significant decrease in the rate of in situ
thrombosis was observed in patients who received
heparin during the procedure (28% vs 11%, p = 0.04).
The study also showed that the type of venous can-
nulation significantly affected the in situ thrombo-
sis rate independently of the heparinization proto-
col. The rate of in situ thrombosis was higher in the
single venous puncture group, regardless of the he-
parinization protocol (16% vs 6%, p = 0.1 in the
group on heparin and 38% vs 18%, p = 0.04 in the
other group). In the single venous puncture group
(n = 100), heparinization significantly decreased the
rate of in situ thrombosis (16% vs 38%, p = 0.023)
compared to that of the other study group (6% vs
18%, p = 0.12; Table 3). Advanced age had no ef-
fect on the rate of in situ thrombosis. Surprisingly,
there was a significantly higher rate of thrombosis
among women than men (26% vs 11%, p = 0.01),
regardless of the heparinization protocol or the type
of cannulation.
There was an insignificant increase in the rate of
in situ thrombosis with an increasing number of DVT
risk factors (0RF: 18%, 1RF: 22%, 2RF: 33%, p = 0.6).
The number of catheters had no effect on thrombo-
sis, independent of the cannulation type (p = 0.29),
and the same result was found for the number of nee-
dle insertions (p = 0.28). The duration of the proce-
dure was significantly longer in patients with in situ
thrombosis (mean 96 ± 110 min, p = 0.019) indepen-
dent of the type of cannulation (p = 0.7), the heparini-
zation protocol (p = 0.7), or gender (p = 0.14).
Ultrasound results after 24 hours. There was
one case of superficial thrombophlebitis, four cases
of hematoma, and no DVT. There was an insignifi-
cant increase in the hematoma rate for the single
puncture approach relative to separate cannulation
(3% vs 1%, p = 0.3). The rate of hematoma was sim-
ilar in the heparin group and the control group.
Discussion
Main findings
This study demonstrated a clear difference be-
tween various methods of cannulation in the femo-
ral area. There were several main findings from this
study. Firstly, DVT is a very rare complication and
independent of the type of cannulation or heparin
injection. Therefore, heparinization was not neces-
sary to reduce DVT after right-sided procedures.
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Secondly, in situ thrombosis depends on the can-
nulation type and heparinization during a procedure.
Thrombus formation in iliofemoral veins, and
local complications such as hematoma formation and
long-lasting pain in the femoral area, are well-known
complications after EPS procedures. Risk factors for
these complications and prophylactic modalities are
less defined. Chen et al. [10] reported the results of
multiple sheath placements related to DVT and the
complications encountered when using duplex ultra-
sonography. They observed a significant incidence
(17.6%) of non-occlusive DVT after multiple sheath
placements for EPS or RFCA therapy. Nonetheless,
most thrombi regressed after one week of follow-up.
Furthermore, there was no significant difference in
the incidence of major complications when multiple
sheaths placement was compared to single sheath
placement. In their study, all of the venous thrombi
were non-occlusive and asymptomatic. None of the
femoral veins developed occlusive DVT.
Table 2. The rate of thrombosis considering the probable risk factors.
In situ thrombosis P
YES number Percentage NO number Percentage
Hemoglobin ≥ 12 21 17.2% 101 82.8%
10–12 15 23.1% 50 76.9% 0.5
< 10 3 25% 9 75%
Left ventricular function Normal 35 20.7% 134 79.3%
Mild 1 16.7% 5 83.3%
0.2Moderate 0 0 14 100%
Severe 3 30% 7 70%
Diabetes mellitus No 34 18.9% 146 81.1%
Yes 5 26.3% 14 73.7% 0.5
Smoking No 36 19.7% 147 80.3%
1Yes 3 18.8% 13 81.3%
Acetylsalicylic acid No 27 19.7% 110 80.3%
1Yes 12 19.4% 50 80.6%
Deep vein thrombosis 0 28 18.4% 124 81.6%
risk factor (N) 1 10 22.7% 34 77.3% 0.6
2 1 33.3% 2 66.7%
Obesity No 35 19.4% 145 80.6%
0.7Yes 4 21.1% 15 78.9%
Mean Mean
Number of needle insertions 2.94 3.76 0.28
Number of catheters 2.3 2.4 0.29
Age 42.5 47.3 0.12
Table 3. The rate of thrombosis according to type of cannulation/heparin protocol/sex.
In situ thrombosis P
YES number Percentage NO number Percentage
Sex Male* 10 11.4% 78 88.6%
0.011Female 29 26.1% 82 73.9%
Male Female
Heparin protocol Was done 49 55.1% 51 45.9%
0.25Not done 40 44.9% 60 54.1%
Type of cannulation One-line 45 50.6% 55 49.5%
1
Separate 44 49.4% 56 50.6%
*One male patient had missing data for in situ thrombosis
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Correlation between different types
of cannulation and local venous complication
We compared the incidence of complications
between patients with two different types of cannu-
lation. The rate of in situ thrombosis was significantly
higher in the single venous puncture group vs the
separate cannulation group (27% vs 12%, p = 0.012).
This was independent of the heparinization proto-
col, the duration of the procedure, or gender. This
can be explained by the presence of more local pres-
sure and stasis in the one-line cannulation group.
We used ultrasound to analyze the catheterization site
24 hours after the procedure to look for superficial
thrombophlebitis, hematoma, and DVT. There was no
significant difference between the two groups. The
rarity of DVT in the absence of a history of previous
thromboemboli shows that venous catheters are safe,
even in those with long procedures.
Relationship between the in situ
thrombosis and heparinization
Heparinization with a 5,000-U loading dose fol-
lowed by ACT monitoring was associated with
a significantly lower rate of in situ thrombosis in-
dependent of other determinants, without increas-
ing the rate of other complications (such as hemato-
ma formation).
This effect was more prominent and significant
in the one-line cannulation group.
These results suggest that heparinization may
be useful in reducing this minor complication in all
RFCA or EPS procedures, but the clinical and par-
aclinical benefits were more promising in patients
undergoing one-line cannulation.
In women, or during procedures that last a long
time (mean 110 min), heparinization may be useful.
Other conventional or possible risk factors for
hypercoagulability such as underlying heart disease,
left ventricular systolic function, anemia (hemoglo-
bin < 12), smoking, obesity, the number of DVT risk
factors, the number of catheters required, and dia-
betes were not significantly correlated with the in-
cidence of in situ thrombosis.
Ultrasound results after 24 hours. We at-
tempted to assess venous insufficiency and throm-
bophlebitis as predictors of DVT and hypercoagu-
bility, but in this study, the incidences of these fac-
tors were insignificant. This can be explained by the
exclusion of very high risk patients.
Limitations of the study
The data presented was collected in a single-
center feasibility study. The results may be limit-
ed by the relatively small sample size. A much larg-
er prospective randomized study is warranted. High
risk patients for thromboemboli were excluded from
the study.
Clinical implications
Given the local venous complications and DVT
after EPS procedures, heparinization was not nec-
essary for right-sided EPS procedures. In situ
thrombosis is a minor complication that can be re-
duced by heparinization in patients undergoing one-
line cannulation.
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